ArcticZymes technologies launches the following products: ArcticZymes R2DTM Ligase – Patent pending ligase with novel specificity enabling the ligation of DNA to both ends of RNA using a DNA splint. The enzyme is an enabling tool for new technology development and is expected to have broad applicability in Molecular Diagnostics (MDx), Next Generation Sequencing (NGS), and gene/RNA synthesis applications …

Tromsø, Norway, 8th October 2021 ArcticZymes is pleased to announce the launch of a new application page including a protocol in how to use Cod UNG as a contamination control in RT-LAMP to effectively eliminate carry-over contaminants and restore assay sensitivity. For more information, visit our application page or contact us.

Tromsø, Norway, 08 July, 2020: Currently there is a large demand for rapid and reliable point-of-care (POC) diagnostic tests for viral and bacterial pathogens to expedite clinical decision making and control disease spread. When establishing these new POC assays, the use of robust components allowing amplification directly from biological sample material is essential. Our new optimized IsoPol BST+ 10X Reaction …